Webinars.
Educational insights about GARD
When you watch our webinars, you will learn in what ways GARD can support your testing needs. We cover essential topics that range from genomics and machine learning and why GARD has such robust prediction for in vitro sensitization testing, to difficult-to-test samples and quantitative potency assessment.
© SenzaGen
Interested in more information?
Contact us to discuss how the GARD assays can support your testing needs.
April 14, 2021
SenzaGen’s 2021 SOT poster presentations
By Dr Henrik Johansson and Dr Ron Brown
- Poster #1. Quantitative Sensitizing Potency Assessment Using GARD™skin Dose-Response | Download a copy
- Poster #2. Applicability Domain of the GARD™skin Medical Device Test for In Vitro Skin Sensitization Testing of Medical Devices (MDCPSS Best Overall Abstract) | Download a copy
June 17, 2020
Web-based launch: The NEW GARDskin Dose-Response
By Andy Forreryd, PhD, SenzaGen AB
May 26, 2020
Genomics and Machine Learning for In Vitro Sensitization Testing of Challenging Chemicals
By Henrik Johansson, PhD, and Andy Forreryd, PhD, SenzaGen AB
March 26, 2020
Web-based conference on “Difficult-to-test” substances and regulatory testing
By Andy Forreryd, SenzaGen AB and guest speakers from Eurofins, Lubrizol and MB Research Labs
Session recordings
Dr Andy Forreryd, SenzaGen
Helge Gehrke, Eurofins BioPharma Product Testing
Dr. George DeGeorge, MB Research Labs
February, 2020
In vitro sensitization testing based on genomics and machine learning
By Angelica Johansson, SenzaGen AB
October, 2019
In vitro sensitization testing of Medical Devices – GARDskin Medical Device
By Rose-Marie Jenvert, PhD, SenzaGen
September 2019
How are the in vitro GARD™ assays used in real life? – Cases and applications for testing of skin and respiratory sensitizers
By Andy Forreryd, PhD, SenzaGen
April 2019
Genomics and Machine Learning – All you need to know about the GARD™ technology for in vitro sensitization testing
By Andy Forreryd, PhD, SenzaGen